Healthcare -
Biotechnology - NASDAQ - US
$ 1.055
-4.09 %
$ 55.6 M
Market Cap
-0.36
P/E
Price Target
Average
1795.73%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
29.50%
Net Income
Estimate
31.69%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ALX Oncology Holdings Inc.
Wall Street analysts predict an average 1-year price target for ALXO of $20 , with forecasts ranging from
a
low of
$14 to a high of $25 .
ALXO Lowest Price Target
Wall Street Target
14 USD
1227.01%
ALXO Average Price Target
Wall Street Target
20 USD
1795.73%
ALXO Highest Price Target
Wall Street Target
25 USD
2269.67%
REVENUE FORECAST
Revenue Forecast Chart ALXO
EBIT FORECAST
EBIT Forecast Chart ALXO
NET INCOME FORECAST
Net Income Chart ALXO